<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03513744</url>
  </required_header>
  <id_info>
    <org_study_id>JEN/008017</org_study_id>
    <nct_id>NCT03513744</nct_id>
  </id_info>
  <brief_title>Study Evaluating Growth and Tolerance of Infant Formula Containing HMOs</brief_title>
  <official_title>Evaluation of Nutritional Suitability and Tolerability of a Human Milk Oligosaccharide (HMO) Mix in Infant Formula for Term Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jennewein Biotechnologie GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jennewein Biotechnologie GmbH</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this clinical study is to investigate the suitability of an infant
      formula containing five different human milk oligosaccharides to support normal physical
      growth (evaluated per weight gain), in comparison with infant formula without human milk
      oligosaccharides, when the formula is fed as the sole source of nutrition.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main goal of the study is to investigate the suitability of an infant formula containing
      five different human milk oligosaccharides to support normal physical growth of term infants
      (evaluated per weight gain, body length and head circumference), in comparison with infant
      formula without human milk oligosaccharides, when the formula is fed exclusivly in the first
      four month of life. Additionally, a comparison of the two formula fed groups against a
      reference group with breastfed infants as well as the WHO growth standard reference tables
      will be performed. An assessment of safety and tolerability will be performed as well.

      As a secondary out come of the study, we will examine the effect of the formula on the infant
      microbiome, as well as the HMO status of the mother's milk towards the microbial composition
      of the infant microbiome.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2018</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>assessment of body weight (in grams) of term infants</measure>
    <time_frame>4 month</time_frame>
    <description>growth, assessed by body weight gain, of term infants from enrollment to 4 month of life</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>assessment of body length (in centimeter) of term infants</measure>
    <time_frame>4 month</time_frame>
    <description>growth, assessed as body length, of term infants from enrollment to 4 month of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>assessment of head circumference (in centimeter) of term infants</measure>
    <time_frame>4 month</time_frame>
    <description>growth, assessed as head circumference, of term infants from enrollment to 4month of life</description>
  </secondary_outcome>
  <other_outcome>
    <measure>digestive tolerance</measure>
    <time_frame>4 month</time_frame>
    <description>stool frequency and consistency</description>
  </other_outcome>
  <other_outcome>
    <measure>influence of digestion</measure>
    <time_frame>4 month</time_frame>
    <description>digestive tolerance parameters ( e.g. rigurgitation, flatulence) will be assessed</description>
  </other_outcome>
  <other_outcome>
    <measure>influence on behaviour</measure>
    <time_frame>4 month</time_frame>
    <description>behavior patterns (e.g.fussiness, cramps, awakings at night) will be assessed</description>
  </other_outcome>
  <other_outcome>
    <measure>product compliance</measure>
    <time_frame>4 month</time_frame>
    <description>intake of infant formula in ml</description>
  </other_outcome>
  <other_outcome>
    <measure>morbidity</measure>
    <time_frame>4 month</time_frame>
    <description>observation of illness</description>
  </other_outcome>
  <other_outcome>
    <measure>stool microbiota</measure>
    <time_frame>4 month</time_frame>
    <description>analysis of the fecal microbiota</description>
  </other_outcome>
  <other_outcome>
    <measure>HMO composition in breast milk</measure>
    <time_frame>4 month</time_frame>
    <description>analysis of HMO composition in mothers breastmilk in the breast-fed arm</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Infant Nutrition</condition>
  <arm_group>
    <arm_group_label>infant formula containing five HMOs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>infant formula</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>breast milk group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>human milk oligosaccharides</intervention_name>
    <description>mixture of five different human milk oligosaccharides</description>
    <arm_group_label>infant formula containing five HMOs</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton birth

          -  Full-term infant (37 - 42 weeks of gestational age)

          -  APGAR score of 9 or 10

          -  Birth weight 2500 - 4500 g

        Exclusion Criteria:

          -  clinically significant condition/ disorder

          -  Adverse maternal of fetal medical history that may influence growth/development of the
             subject or tolerance of the infant formula

          -  readmission to hospital (except for hyperbilirubinemia)

          -  allergy to cow's milk

          -  participation in another study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>13 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frank Jochum, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaetmedizin Berlin, Charit√©</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kaja Parschat, Ph.D</last_name>
    <phone>+ 4922249197344</phone>
    <email>katja.parschat@jennewein-biotech.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stefan Jennewein, Ph.D</last_name>
    <phone>+4922249894501</phone>
    <email>stefan.jennewein@jennewein-biotech.de</email>
  </overall_contact_backup>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 12, 2018</study_first_submitted>
  <study_first_submitted_qc>April 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 2, 2018</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>human milk oligosaccharides</keyword>
  <keyword>infant formula</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

